Literature DB >> 12815674

Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra.

Melissa Terpstra1, Pierre-Gilles Henry, Rolf Gruetter.   

Abstract

The concentration of reduced glutathione (GSH), an antioxidant, may be altered in various brain diseases. MEGA-PRESS was used to edit for the (1)H NMR signal from GSH in the occipital lobe of 12 normal humans. In all studies, GSH was clearly detected with a spectral pattern consistent with spectra acquired from a phantom containing GSH. Retention of singlet resonances in the subspectra, a key advantage of this difference-editing technique, provided an unambiguous reference for the offset and phase of the edited signal. Linear combination model (LCModel) analysis provided an unbiased means for quantifying signal contribution from edited metabolites. GSH concentration was estimated from the in vivo spectra as 1.3 +/- 0.2 micro mol/g (mean +/- SD, n = 12). Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815674     DOI: 10.1002/mrm.10499

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  60 in total

1.  Noninvasive quantification of T2 and concentrations of ascorbate and glutathione in the human brain from the same double-edited spectra.

Authors:  Uzay E Emir; Dinesh Deelchand; Pierre-Gilles Henry; Melissa Terpstra
Journal:  NMR Biomed       Date:  2010-10-06       Impact factor: 4.044

Review 2.  MR spectroscopy and spectroscopic imaging of the brain.

Authors:  He Zhu; Peter B Barker
Journal:  Methods Mol Biol       Date:  2011

3.  Noninvasive quantification of ascorbate and glutathione concentration in the elderly human brain.

Authors:  Uzay E Emir; Susan Raatz; Susan McPherson; James S Hodges; Carolyn Torkelson; Pierre Tawfik; Tonya White; Melissa Terpstra
Journal:  NMR Biomed       Date:  2011-01-12       Impact factor: 4.044

4.  Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3 T instrument and its dependence on brain region and the female menstrual cycle.

Authors:  Masafumi Harada; Hitoshi Kubo; Ayumi Nose; Hiromu Nishitani; Tsuyoshi Matsuda
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

5.  Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

Authors:  Dikoma C Shungu; Nora Weiduschat; James W Murrough; Xiangling Mao; Sarah Pillemer; Jonathan P Dyke; Marvin S Medow; Benjamin H Natelson; Julian M Stewart; Sanjay J Mathew
Journal:  NMR Biomed       Date:  2012-01-27       Impact factor: 4.044

Review 6.  Use of electron paramagnetic resonance spectroscopy to evaluate the redox state in vivo.

Authors:  Harold M Swartz; Nadeem Khan; Valery V Khramtsov
Journal:  Antioxid Redox Signal       Date:  2007-10       Impact factor: 8.401

7.  Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia.

Authors:  Melissa Terpstra; T J Vaughan; Kamil Ugurbil; Kelvin O Lim; S Charles Schulz; Rolf Gruetter
Journal:  MAGMA       Date:  2005-11-18       Impact factor: 2.310

8.  Echo time optimization for J-difference editing of glutathione at 3T.

Authors:  Kimberly L Chan; Nicolaas A J Puts; Karim Snoussi; Ashley D Harris; Peter B Barker; Richard A E Edden
Journal:  Magn Reson Med       Date:  2016-02-25       Impact factor: 4.668

Review 9.  Edited 1 H magnetic resonance spectroscopy in vivo: Methods and metabolites.

Authors:  Ashley D Harris; Muhammad G Saleh; Richard A E Edden
Journal:  Magn Reson Med       Date:  2017-02-02       Impact factor: 4.668

10.  (1)H MRS detection of glycine residue of reduced glutathione in vivo.

Authors:  Lana G Kaiser; Małgorzata Marjańska; Gerald B Matson; Isabelle Iltis; Seth D Bush; Brian J Soher; Susanne Mueller; Karl Young
Journal:  J Magn Reson       Date:  2009-11-26       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.